Jul 18 |
Novartis Reports Near 40% Margin In Q2; Shares Slide
|
Jul 18 |
Novartis reports 43% increase in net income in Q2 2024
|
Jul 18 |
2 Magnificent Stocks to Buy With $500
|
Jul 18 |
TSMC and Netflix rise premarket; Domino's Pizza, Beyond Meat fall
|
Jul 18 |
Earnings summary: Novartis beats Q2 earnings estimates; raises FY2024 bottom-line guidance
|
Jul 18 |
Novartis Raises Profit Guidance as Key Drugs Boost Sales
|
Jul 18 |
Novartis beats top-line and bottom-line estimates; raises FY24 core operating income outlook
|
Jul 18 |
Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance
|
Jul 17 |
Novartis Q2 2024 Earnings Preview
|
Jul 16 |
Here’s Why Aristotle Capital’s International Equity Composite Sold Novartis AG (NVS)
|